SLATE-GRAY COLOR IN PATIENTS RECEIVING CHLORPROMAZINE.
D001129:Argyria; D002746:Chlorpromazine; D002856:Chromatophores; D017484:Dermatitis, Phototoxic; D003937:Diagnosis, Differential; D004358:Drug Therapy; D005145:Face; D006225:Hand; D006801:Humans; D007099:Imipramine; D008543:Melanins; D008774:Methylphenidate; D009333:Neck; D010276:Parasympatholytics; D010336:Pathology; D010546:Perphenazine; D010787:Photosensitivity Disorders; D010859:Pigmentation Disorders; D011346:Prochlorperazine; D012110:Reserpine; D014116:Toxicology; D014268:Trifluoperazine; D014282:Trihexyphenidyl
D008543:Melanins; D010276:Parasympatholytics; D008774:Methylphenidate; D014268:Trifluoperazine; D014282:Trihexyphenidyl; D012110:Reserpine; D010546:Perphenazine; D007099:Imipramine; D002746:Chlorpromazine; D011346:Prochlorperazine
ARGYRIA; CHLORPROMAZINE; CHROMATOPHORES; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY; FACE; HAND; IMIPRAMINE; MELANIN; METHYLPHENIDATE; NECK; PARASYMPATHOLYTICS; PATHOLOGY; PERPHENAZINE; PHOTOSENSITIZATION; PIGMENTATION DISORDERS; PROCHLORPERAZINE; RESERPINE; TOXICOLOGIC REPORT; TRIFLUOPERAZINE; TRIHEXYPHENIDYL